The DOI matches its Crossref record.
Induction of tolerance by IL-10-treated dendritic cells
Abstract
Dendritic cells (DC) form a specialized system for presenting Ag to naive or quiescent T cells and consequently play a central role in the induction of T and B cell immunity. In this study we used DC generated from peripheral progenitors to analyze the effect of IL-10 on the accessory function of human DC. We demonstrate that immature DC, harvested on days 9 to 11 and exposed to IL-10 for the last 2 days of culture, show a strongly reduced capacity to stimulate a CD4+ T cell response in an allogeneic MLR in a dose-dependent manner. In contrast, fully mature DC are completely resistant to the effects of IL-10. These results were obtained in both an alloantigen-induced MLR and an anti-CD3 mAb-induced response of primed and naive (CD45RA+) CD4+ T cells. FACS analysis revealed inhibition of the up-regulation of the costimulatory molecules CD58 and CD86 and the specific DC marker CD83 in DC pretreated with IL-10. These data suggest that IL-10 inhibited the development of fully mature DC. Furthermore, DC precultured with IL-10, but not controls, induced a state of alloantigen-specific anergy in CD4+ T cells and of peptide-specific anergy in the influenza hemagglutinin-specific T cell clone HA1.7. Analysis of the supernatants of these anergic T cells revealed a reduced production of IL-2 and IFN-gamma compared with that in control cells. Collectively, these data suggest that IL-10 converts immature DC into tolerogenic APC, which might be a useful tool in the therapy of patients with autoimmune or allergic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Cancer immunotherapy via dendritic cells
Palucka, K., & Banchereau, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3258 · Cited by 2,049
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
Togashi, Y., Shitara, K., & Nishikawa, H. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0175-7 · Cited by 1,546
Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., & Enk, A. H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1213 · Cited by 1,538
Self-citationDendritic-cell control of pathogen-driven T-cell polarization
Kapsenberg, M. L. (2003) · Nature Reviews Immunology · doi:10.1038/nri1246 · Cited by 1,437
Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?
Lutz, M. B., & Schuler, G. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02281-0 · Cited by 1,349
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314
Penna, G., & Adorini, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2405 · Cited by 1,267
Regulatory T cells in the control of immune pathology
Maloy, K. J., & Powrie, F. (2001) · Nature Immunology · doi:10.1038/ni0901-816 · Cited by 1,175
Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans
Grazia Roncarolo, M., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K., & Levings, M. K. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00420.x · Cited by 1,173
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
Steinman, R. M., & Nussenzweig, M. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231606698 · Cited by 1,166
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028
Mechanisms and functional significance of tumour-induced dendritic-cell defects
Gabrilovich, D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1498 · Cited by 1,024
Brown, J. A., Dorfman, D. M., Ma, F.-R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A., & Freeman, G. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1257 · Cited by 968
T-cell priming by type-1and type-2 polarized dendritic cells: the concept of a third signal
Kaliński, P., Hilkens, C. M. U., Wierenga, E. A., & Kapsenberg, M. L. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01547-9 · Cited by 933
Cheng, P., Corzo, C. A., Luetteke, N., Yu, B., Nagaraj, S., Bui, M. M., Ortiz, M., Nacken, W., Sorg, C., Vogl, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080132 · Cited by 902
Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., & Carbone, D. P. (1998) · Blood · doi:10.1182/blood.v92.11.4150 · Cited by 1,048
Immunological mechanisms of allergen-specific immunotherapy
Larché, M., Akdis, C. A., & Valenta, R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1934 · Cited by 849
Awasthi, A., Carrier, Y., Peron, J. P. S., Bettelli, E., Kamanaka, M., Flavell, R. A., Kuchroo, V. K., Oukka, M., & Weiner, H. L. (2007) · Nature Immunology · doi:10.1038/ni1541 · Cited by 804
Sparwasser, T., Koch, E.-S., Vabulas, R. M., Heeg, K., Lipford, G. B., Ellwart, J. W., & Wagner, H. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199806)28:06<2045::aid-immu2045>3.0.co;2-8 · Cited by 794
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O’Mahony, L., Palomares, O., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 778
SERAFINI, P., BORRELLO, I., & BRONTE, V (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.005 · Cited by 762
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression
Gottfried, E., Kunz-Schughart, L. A., Ebner, S., Mueller-Klieser, W., Hoves, S., Andreesen, R., Mackensen, A., & Kreutz, M. (2006) · Blood · doi:10.1182/blood-2005-05-1795 · Cited by 729
Taylor, A., Verhagen, J., Blaser, K., Akdis, M., & Akdis, C. A. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02321.x · Cited by 720
Goerdt, S., & Orfanos, C. E. (1999) · Immunity · doi:10.1016/s1074-7613(00)80014-x · Cited by 682
Dendritic Cells in Cancer Immunotherapy
Fong, L., & Engleman, E. G. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.245 · Cited by 680
Dendritic cell subsets in cancer immunity and tumor antigen sensing
Del Prete, A., Salvi, V., Soriani, A., Laffranchi, M., Sozio, F., Bosisio, D., & Sozzani, S. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-00990-6 · Cited by 644
Piemonti, L., Monti, P., Sironi, M., Fraticelli, P., Leone, B. E., Dal Cin, E., Allavena, P., & Di Carlo, V. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4443 · Cited by 623
Menetrier-Caux, C., Montmain, G., Dieu, M. C., Bain, C., Favrot, M. C., Caux, C., & Blay, J. Y. (1998) · Blood · doi:10.1182/blood.v92.12.4778 · Cited by 590
Shouval, D. S., Biswas, A., Goettel, J. A., McCann, K., Conaway, E., Redhu, N. S., Mascanfroni, I. D., Al Adham, Z., Lavoie, S., Ibourk, M., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.03.011 · Cited by 584
Gregori, S., Tomasoni, D., Pacciani, V., Scirpoli, M., Battaglia, M., Magnani, C. F., Hauben, E., & Roncarolo, M.-G. (2010) · Blood · doi:10.1182/blood-2009-07-234872 · Cited by 561
Menges, M., Rößner, S., Voigtländer, C., Schindler, H., Kukutsch, N. A., Bogdan, C., Erb, K., Schuler, G., & Lutz, M. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011341 · Cited by 556
IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation
Park, S.-J., Nakagawa, T., Kitamura, H., Atsumi, T., Kamon, H., Sawa, S.-I., Kamimura, D., Ueda, N., Iwakura, Y., Ishihara, K., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3844 · Cited by 519
Steinbrink, K., Jonuleit, H., Müller, G., Schuler, G., Knop, J., & Enk, A. H. (1999) · Blood · doi:10.1182/blood.v93.5.1634 · Cited by 511
Self-citationDevelopment of Th1-Inducing Capacity in Myeloid Dendritic Cells Requires Environmental Instruction
Vieira, P. L., de Jong, E. C., Wierenga, E. A., Kapsenberg, M. L., & Kaliński, P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4507 · Cited by 502
Myeloid-derived suppressor cells in cancer and cancer therapy
Lasser, S. A., Ozbay Kurt, F. G., Arkhypov, I., Utikal, J., & Umansky, V. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00846-y · Cited by 489
Dendritic Cell Vaccines for Cancer Immunotherapy
Timmerman, M., & Levy, M. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.507 · Cited by 485
Dendritic Cells and Their Role in Immunotherapy
Gardner, A., de Mingo Pulido, Á., & Ruffell, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00924 · Cited by 485
Differentiation of T Regulatory Cells by Immature Dendritic Cells
Roncarolo, M.-G., Levings, M. K., & Traversari, C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.f5 · Cited by 483
Thurner, B., Röder, C., Dieckmann, D., Heuer, M., Kruse, M., Glaser, A., Keikavoussi, P., Kämpgen, E., Bender, A., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00208-7 · Cited by 482
Dieckmann, D., Bruett, C. H., Ploettner, H., Lutz, M. B., & Schuler, G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020642 · Cited by 467
Dendritic Cells: Immune Regulators in Health and Disease
Lipscomb, M. F., & Masten, B. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00023.2001 · Cited by 465
Dendritic cells as a tool to induce anergic and regulatory T cells
Jonuleit, H., Schmitt, E., Steinbrink, K., & Enk, A. H. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01952-4 · Cited by 464
Self-citationSteinbrink, K., Graulich, E., Kubsch, S., Knop, J., & Enk, A. H. (2002) · Blood · doi:10.1182/blood.v99.7.2468 · Cited by 448
Self-citationThe Regulatory T Cell Family: Distinct Subsets and their Interrelations
Jonuleit, H., & Schmitt, E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6323 · Cited by 436
Self-citationDendritic cell subsets in health and disease
Ueno, H., Klechevsky, E., Morita, R., Aspord, C., Cao, T., Matsui, T., Di Pucchio, T., Connolly, J., Fay, J. W., Pascual, V., et al. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00551.x · Cited by 430
Davidson, D. J., Currie, A. J., Reid, G. S. D., Bowdish, D. M. E., MacDonald, K. L., Ma, R. C., Hancock, R. E. W., & Speert, D. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1146 · Cited by 429
Diversity in the contribution of interleukin‐10 to T‐cell‐mediated immune regulation
Maynard, C. L., & Weaver, C. T. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00711.x · Cited by 402
Vaccination Strategies for Mucosal Immune Responses
Ogra, P. L., Faden, H., & Welliver, R. C. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.2.430-445.2001 · Cited by 390
Harizi, H., Juzan, M., Pitard, V., Moreau, J.-F., & Gualde, N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2255 · Cited by 384
Immature, but not inactive: the tolerogenic function of immature dendritic cells
Mahnke, K., Schmitt, E., Bonifaz, L., Enk, A. H., & Jonuleit, H. (2002) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2002.01115.x · Cited by 384
Self-citationUterine DCs are crucial for decidua formation during embryo implantation in mice
Plaks, V., Birnberg, T., Berkutzki, T., Sela, S., BenYashar, A., Kalchenko, V., Mor, G., Keshet, E., Dekel, N., Neeman, M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36682 · Cited by 381
Impact of LL-37 on anti-infective immunity
Bowdish, D. M. E., Davidson, D. J., Lau, Y. E., Lee, K., Scott, M. G., & Hancock, R. E. W. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0704380 · Cited by 374
Dendritic cell-mediated T cell polarization
de Jong, E. C., Smits, H. H., & Kapsenberg, M. L. (2005) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0167-1 · Cited by 367
Direct and Indirect Inhibition of Th1 Development by Progesterone and Glucocorticoids
Miyaura, H., & Iwata, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1087 · Cited by 361
Kanto, T., Hayashi, N., Takehara, T., Tatsumi, T., Kuzushita, N., Ito, A., Sasaki, Y., Kasahara, A., & Hori, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5584 · Cited by 356
Roncarolo, M. G., Gregori, S., Bacchetta, R., Battaglia, M., & Gagliani, N. (2018) · Immunity · doi:10.1016/j.immuni.2018.12.001 · Cited by 355
Vicari, A. P., & Caux, C. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00033-8 · Cited by 351
“[140] Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH.”
BackgroundBrown, R. D., Pope, B., Murray, A., Esdale, W., Sze, D. M., Gibson, J., Ho, P. J., Hart, D., & Joshua, D. (2001) · Blood · doi:10.1182/blood.v98.10.2992 · Cited by 347
Chauveau, C., Rémy, S., Royer, P. J., Hill, M., Tanguy-Royer, S., Hubert, F.-X., Tesson, L., Brion, R., Beriou, G., Gregoire, M., et al. (2005) · Blood · doi:10.1182/blood-2005-02-0494 · Cited by 342
Dendritic cell dysfunction in cancer: A mechanism for immunosuppression
Pinzon‐Charry, A., Maxwell, T., & López, J. A. (2005) · Immunology & Cell Biology · doi:10.1111/j.1440-1711.2005.01371.x · Cited by 328
Modulating vaccine responses with dendritic cells and Toll‐like receptors
Pulendran, B. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00144.x · Cited by 325
Alternative versus Classical Activation of Macrophages
Goerdt, S., Politz, O., Schledzewski, K., Birk, R., Gratchev, A., Guillot, P., Hakiy, N., Klemke, C.-D., Dippel, E., Kodelja, V., et al. (1999) · Pathobiology · doi:10.1159/000028096 · Cited by 324
PD‐L1 expression on tolerogenic APCs is controlled by STAT‐3
Wölfle, S. J., Strebovsky, J., Bartz, H., Sähr, A., Arnold, C., Kaiser, C., Dalpke, A. H., & Heeg, K. (2011) · European Journal of Immunology · doi:10.1002/eji.201040979 · Cited by 323
High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells
Manavalan, J. S., Rossi, P. C., Vlad, G., Piazza, F., Yarilina, A., Cortesini, R., Mancini, D., & Suciu-Foca, N. (2003) · Transplant Immunology · doi:10.1016/s0966-3274(03)00058-3 · Cited by 319
Nefedova, Y., Nagaraj, S., Rosenbauer, A., Muro-Cacho, C., Sebti, S. M., & Gabrilovich, D. I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0529 · Cited by 318
A role for CD36 in the regulation of dendritic cell function
Urban, B. C., Willcox, N., & Roberts, D. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151028698 · Cited by 318
A review of the current use of rituximab in autoimmune diseases
Gürcan, H. M., Keskin, D. B., Stern, J. N. H., Nitzberg, M. A., Shekhani, H., & Ahmed, A. R. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2008.10.004 · Cited by 314
Sato, K., Yamashita, N., Yamashita, N., Baba, M., & Matsuyama, T. (2003) · Immunity · doi:10.1016/s1074-7613(03)00055-4 · Cited by 313
The role of decidual immune cells on human pregnancy
Liu, S., Diao, L., Huang, C., Li, Y., Zeng, Y., & Kwak-Kim, J. Y. H. (2017) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2017.10.045 · Cited by 308
Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin
Bayry, J., Lacroix-Desmazes, S., Carbonneil, C., Misra, N., Donkova, V., Pashov, A., Chevailler, A., Mouthon, L., Weill, B., Bruneval, P., et al. (2003) · Blood · doi:10.1182/blood-2002-05-1447 · Cited by 306
Interleukin 10 Receptor Signaling
Shouval, D. S., Ouahed, J., Biswas, A., Goettel, J. A., Horwitz, B. H., Klein, C., Muise, A. M., & Snapper, S. B. (2014) · Advances in Immunology · doi:10.1016/b978-0-12-800267-4.00005-5 · Cited by 304
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
Sobhani, N., Tardiel-Cyril, D. R., Davtyan, A., Generali, D., Roudi, R., & Li, Y. (2021) · Cancers · doi:10.3390/cancers13061440 · Cited by 303
Diehl, L., Schurich, A., Grochtmann, R., Hegenbarth, S., Chen, L., & Knolle, P. A. (2008) · Hepatology · doi:10.1002/hep.21965 · Cited by 291
Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction
Morelli, A. E., & Thomson, A. W. (2003) · Immunological Reviews · doi:10.1046/j.1600-065x.2003.00079.x · Cited by 283
Wei, J., Barr, J., Kong, L.-Y., Wang, Y., Wu, A., Sharma, A. K., Gumin, J., Henry, V., Colman, H., Priebe, W., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0734 · Cited by 282
Strauss, L., Bergmann, C., Gooding, W., Johnson, J. T., & Whiteside, T. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1403 · Cited by 281
Targeting STAT3 affects melanoma on multiple fronts
Kortylewski, M., Jove, R., & Yu, H. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-1580-1 · Cited by 280
Immunological mechanisms of allergen-specific immunotherapy
Jutel, M., & Akdis, C. A. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02589.x · Cited by 279
Tr1 cells: From discovery to their clinical application
Battaglia, M., Gregori, S., Bacchetta, R., & Roncarolo, M.-G. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.01.007 · Cited by 279
Bell, D., Young, J. W., & Banchereau, J. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60023-1 · Cited by 277
Molecular Characterization of Human 4Ig-B7-H3, a Member of the B7 Family with Four Ig-Like Domains
Steinberger, P., Majdic, O., Derdak, S. V., Pfistershammer, K., Kirchberger, S., Klauser, C., Zlabinger, G., Pickl, W. F., Stöckl, J., & Knapp, W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2352 · Cited by 276
Modulating the immune response with dendritic cells and their growth factors
Pulendran, B., Banchereau, J., Maraskovsky, E., & Maliszewski, C. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(00)01794-4 · Cited by 263
Selenko-Gebauer, N., Majdic, O., Szekeres, A., Höfler, G., Guthann, E., Korthäuer, U., Zlabinger, G., Steinberger, P., Pickl, W. F., Stockinger, H., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3637 · Cited by 263
Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man
Raker, V. K., Domogalla, M. P., & Steinbrink, K. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00569 · Cited by 259
Self-citationBoks, M. A., Kager-Groenland, J. R., Haasjes, M. S. P., Zwaginga, J. J., van Ham, S. M., & ten Brinke, A. (2012) · Clinical Immunology · doi:10.1016/j.clim.2011.11.011 · Cited by 258
Impaired regulatory T cell function in germ‐free mice
Östman, S., Rask, C., Wold, A. E., Hultkrantz, S., & Telemo, E. (2006) · European Journal of Immunology · doi:10.1002/eji.200535244 · Cited by 256
Dolganiuc, A., Kodys, K., Kopasz, A., Marshall, C., Do, T., Romics, L., Mandrekar, P., Zapp, M., & Szabo, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5615 · Cited by 255
Innate Immune Cells in Liver Inflammation
Liaskou, E., Wilson, D. V., & Oo, Y. H. (2012) · Mediators of Inflammation · doi:10.1155/2012/949157 · Cited by 255
Martin, E., O'Sullivan, B., Low, P., & Thomas, R. (2003) · Immunity · doi:10.1016/s1074-7613(02)00503-4 · Cited by 254
Immunosuppressive CD14+HLA-DRlow/− monocytes in B-cell non-Hodgkin lymphoma
Lin, Y., Gustafson, M. P., Bulur, P. A., Gastineau, D. A., Witzig, T. E., & Dietz, A. B. (2011) · Blood · doi:10.1182/blood-2010-05-283820 · Cited by 244
Zeuthen, L. H., Fink, L. N., & Frokiaer, H. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02687.x · Cited by 227
MIF-Dependent Control of Tumor Immunity
Noe, J. T., & Mitchell, R. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.609948 · Cited by 198
Personalized Dendritic Cell Vaccines‐Recent Breakthroughs and Encouraging Clinical Results
Mastelic-Gavillet, B., Balint, K., Boudousquie, C., Gannon, P. O., & Kandalaft, L. E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00766 · Cited by 189
Induction of potent antitumor immunity by in situ targeting of intratumoral DCs
Furumoto, K., Soares, L., Engleman, E. G., & Merad, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419762 · Cited by 180
Are dendritic cells the key to liver transplant tolerance?
Thomson, A. W., & Lu, L. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01378-4 · Cited by 174
Cohen, N., Mouly, E., Hamdi, H., Maillot, M.-C., Pallardy, M., Godot, V., Capel, F., Balian, A., Naveau, S., Galanaud, P., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2760 · Cited by 170
Immune mechanisms in type 1 diabetes
Wållberg, M., & Cooke, A. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.08.005 · Cited by 155
Metadata
- Authors
- Steinbrink, K., Wölfl, M., Jonuleit, H., Knop, J., & Enk, A. H.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-11
- Volume
- 159
- Issue
- 10
- Pages
- 4772-4780
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1960538598
- Cited by
- 1,246
- References
- 0
- FWCI
- 18.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.